blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2673358

EP2673358 - HEMATOPOIETIC PRECURSOR CELL PRODUCTION BY PROGRAMMING [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.11.2019
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  07.12.2018
FormerGrant of patent is intended
Status updated on  24.07.2018
FormerExamination is in progress
Status updated on  12.12.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
FUJIFILM Cellular Dynamics, Inc.
University Research Park
525 Science Drive, Suite 200
Madison, WI 53711 / US
[2018/26]
Former [2013/51]For all designated states
Cellular Dynamics International, Inc.
University Research Park 525 Science Drive, Suite 200
Madison, WI 53711 / US
Inventor(s)01 / YU, Junying
1265 Meadow Sweet Drive
Madison, WI 53719 / US
02 / VODYANYK, Maksym, A.
13 Drumhill Circle
Madison, WI 53717 / US
 [2014/23]
Former [2013/51]01 / YU, Junying
1265 Meadow Sweet Dr.
Madison, WI 53719 / US
02 / VODYANYK, Maksym, A.
13 Drumhill Circle
Madison, WI 53717 / US
Representative(s)Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2019/02]Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP
Patentanwälte
Prinzregentenstraße 68
81675 München / DE
Former [2013/51]Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstraße 68
81675 München / DE
Application number, filing date12744365.307.02.2012
[2019/02]
WO2012US24098
Priority number, dateUS201161440619P08.02.2011         Original published format: US 201161440619 P
[2013/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012109208
Date:16.08.2012
Language:EN
[2012/33]
Type: A2 Application without search report 
No.:EP2673358
Date:18.12.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 16.08.2012 takes the place of the publication of the European patent application.
[2013/51]
Type: B1 Patent specification 
No.:EP2673358
Date:09.01.2019
Language:EN
[2019/02]
Search report(s)International search report - published on:KR11.10.2012
(Supplementary) European search report - dispatched on:EP31.10.2014
ClassificationIPC:C12N5/0789, A61K35/28
[2018/30]
CPC:
C12N5/0647 (EP,US); A61K35/28 (EP,US); A61P35/00 (EP);
A61P7/00 (EP); A61P7/06 (EP); C12N2501/60 (EP,US);
C12N2501/999 (EP,US); C12N2506/02 (EP,US); C12N2506/45 (EP,US);
C12N2510/00 (EP,US) (-)
Former IPC [2013/51]C12N5/074, C12N5/10, C12N15/63, C12N5/02, A61K35/12
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/51]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:HERSTELLUNG BLUTBILDENDER VORLÄUFERZELLEN DURCH PROGRAMMIERUNG[2013/51]
English:HEMATOPOIETIC PRECURSOR CELL PRODUCTION BY PROGRAMMING[2013/51]
French:PRODUCTION DE PRÉCURSEURS HÉMATOPOÏÉTIQUES OBTENUS PAR PROGRAMMATION[2013/51]
Entry into regional phase21.08.2013National basic fee paid 
21.08.2013Search fee paid 
21.08.2013Designation fee(s) paid 
21.08.2013Examination fee paid 
Examination procedure21.08.2013Examination requested  [2013/51]
28.05.2015Amendment by applicant (claims and/or description)
02.03.2016Despatch of a communication from the examining division (Time limit: M04)
07.07.2016Reply to a communication from the examining division
01.12.2016Despatch of a communication from the examining division (Time limit: M04)
02.03.2017Reply to a communication from the examining division
27.10.2017Despatch of a communication from the examining division (Time limit: M04)
21.12.2017Reply to a communication from the examining division
25.07.2018Communication of intention to grant the patent
03.12.2018Fee for grant paid
03.12.2018Fee for publishing/printing paid
03.12.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.03.2016
Opposition(s)10.10.2019No opposition filed within time limit [2019/51]
Fees paidRenewal fee
27.02.2014Renewal fee patent year 03
11.02.2015Renewal fee patent year 04
10.02.2016Renewal fee patent year 05
10.02.2017Renewal fee patent year 06
14.02.2018Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.02.2012
AL09.01.2019
AT09.01.2019
CY09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
MK09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SI09.01.2019
SK09.01.2019
SM09.01.2019
TR09.01.2019
IE07.02.2019
LU07.02.2019
MT07.02.2019
BE28.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
[2022/31]
Former [2021/32]HU07.02.2012
AL09.01.2019
AT09.01.2019
CY09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SI09.01.2019
SK09.01.2019
SM09.01.2019
TR09.01.2019
IE07.02.2019
LU07.02.2019
MT07.02.2019
BE28.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2021/26]AL09.01.2019
AT09.01.2019
CY09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SI09.01.2019
SK09.01.2019
SM09.01.2019
TR09.01.2019
IE07.02.2019
LU07.02.2019
MT07.02.2019
BE28.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2020/29]AL09.01.2019
AT09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SI09.01.2019
SK09.01.2019
SM09.01.2019
TR09.01.2019
IE07.02.2019
LU07.02.2019
MT07.02.2019
BE28.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2020/17]AL09.01.2019
AT09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SI09.01.2019
SK09.01.2019
SM09.01.2019
TR09.01.2019
IE07.02.2019
LU07.02.2019
BE28.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2020/12]AL09.01.2019
AT09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SI09.01.2019
SK09.01.2019
SM09.01.2019
IE07.02.2019
LU07.02.2019
BE28.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2020/09]AL09.01.2019
AT09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SK09.01.2019
SM09.01.2019
IE07.02.2019
LU07.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2019/52]AL09.01.2019
AT09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SK09.01.2019
SM09.01.2019
LU07.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2019/49]AL09.01.2019
AT09.01.2019
CZ09.01.2019
DK09.01.2019
EE09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RO09.01.2019
RS09.01.2019
SE09.01.2019
SK09.01.2019
LU07.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2019/48]AT09.01.2019
DK09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RS09.01.2019
SE09.01.2019
LU07.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2019/47]AT09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RS09.01.2019
SE09.01.2019
LU07.02.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2019/46]AT09.01.2019
ES09.01.2019
FI09.01.2019
HR09.01.2019
IT09.01.2019
LT09.01.2019
LV09.01.2019
MC09.01.2019
PL09.01.2019
RS09.01.2019
SE09.01.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2019/39]ES09.01.2019
FI09.01.2019
HR09.01.2019
LT09.01.2019
LV09.01.2019
PL09.01.2019
RS09.01.2019
SE09.01.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
IS09.05.2019
PT09.05.2019
Former [2019/38]ES09.01.2019
FI09.01.2019
LT09.01.2019
PL09.01.2019
SE09.01.2019
BG09.04.2019
NO09.04.2019
GR10.04.2019
PT09.05.2019
Former [2019/37]ES09.01.2019
FI09.01.2019
LT09.01.2019
PL09.01.2019
SE09.01.2019
NO09.04.2019
GR10.04.2019
PT09.05.2019
Former [2019/35]ES09.01.2019
FI09.01.2019
LT09.01.2019
PL09.01.2019
SE09.01.2019
NO09.04.2019
PT09.05.2019
Former [2019/34]FI09.01.2019
LT09.01.2019
SE09.01.2019
NO09.04.2019
PT09.05.2019
Former [2019/33]FI09.01.2019
LT09.01.2019
NO09.04.2019
PT09.05.2019
Documents cited:Search[XI]US2007048865  (TANI KENZABURO [JP], et al) [X] 1-3,5,7-10,14 * example 1 * [I] 11-13,15;
 [X]US2008108044  (RAJESH DEEPIKA [US], et al) [X] 1-3,5-10,14 * table 5 *;
 [XI]  - RYO KURITA ET AL, "Tal1/Scl Gene Transduction Using a Lentiviral Vector Stimulates Highly Efficient Hematopoietic Cell Differentiation from Common Marmoset ( Callithrix jacchus ) Embryonic Stem Cells", STEM CELLS, (20060901), vol. 24, no. 9, doi:10.1634/stemcells.2005-0499, ISSN 1066-5099, pages 2014 - 2022, XP055148504 [X] 1-3,5,7-10,14 * page 2016; figure 3 * [I] 11-13,15

DOI:   http://dx.doi.org/10.1634/stemcells.2005-0499
 [X]  - Masaaki Kitajima, "'GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors'", THE EMBO JOURNAL vol. 21, no. 12,, (20020101), pages 3060 - 3069, URL: http://emboj.embopress.org/content/embojnl/21/12/3060.full.pdf, (20140526), XP055120008 [X] 1-3,5,7,10,14 * page 3061; figure 2 *

DOI:   http://dx.doi.org/10.1093/emboj/cdf301
 [X]  - KYUNG-DAL CHOI ET AL, "Hematopoietic and Endothelial Differentiation of Human Induced Pluripotent Stem Cells", STEM CELLS, (20090301), vol. 27, no. 3, doi:10.1634/stemcells.2008-0922, ISSN 1066-5099, pages 559 - 567, XP055035783 [X] 10 * figure 1 *

DOI:   http://dx.doi.org/10.1634/stemcells.2008-0922
 [X]  - A. E. GRIGORIADIS ET AL, "Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells", BLOOD, (20100111), vol. 115, no. 14, doi:10.1182/blood-2009-07-234690, ISSN 0006-4971, pages 2769 - 2776, XP055148017 [X] 10 * figure 1 *

DOI:   http://dx.doi.org/10.1182/blood-2009-07-234690
 [XP]  - JESSICA DIAS ET AL, "Generation of Red Blood Cells from Human Induced Pluripotent Stem Cells", STEM CELLS AND DEVELOPMENT, (20110901), vol. 20, no. 9, doi:10.1089/scd.2011.0078, ISSN 1547-3287, pages 1639 - 1647, XP055148372 [XP] 10 * the whole document *

DOI:   http://dx.doi.org/10.1089/scd.2011.0078
 [XP]  - CHICHA LAURIE ET AL, "Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, US, (20110225), vol. 6, no. 2, doi:10.1371/JOURNAL.PONE.0014733, ISSN 1932-6203, page 8pp, XP009172717 [XP] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0014733
 [T]  - SHI XIAOZHONG ET AL, "Cooperative interaction of Etv2 and Gata2 regulates the development of endothelial and hematopoietic lineages", DEVELOPMENTAL BIOLOGY, (20140226), vol. 389, no. 2, doi:10.1016/J.YDBIO.2014.02.018, ISSN 0012-1606, pages 208 - 218, XP028844506 [T] * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ydbio.2014.02.018
International search[AP]US2012009618  (YU JUNYING [US], et al);
by applicantUS5681599
 US4683202
 EP0412700
 US5030015
 US5302523
 WO9409699
 US5322783
 US5384253
 WO9506128
 US5460964
 US5464765
 US5486359
 US5538877
 US5538880
 US5550318
 US5556954
 US5563055
 US5580859
 WO9639487
 US5589466
 US5591616
 US5610042
 US5635387
 US5656610
 US5677136
 US5702932
 US5716827
 US5736396
 US5736524
 US5750397
 US5759793
 US5780448
 US5789215
 US5811094
 US5827735
 US5827740
 US5837539
 US5837670
 US5843780
 WO9920741
 US5925565
 US5928906
 US5935819
 US5945100
 US5981274
 US5994136
 US5994624
 US6013516
 US6184038
 US2002055144
 US2002102265
 US2003040038
 US2003082561
 WO03042405
 WO03059940
 WO03059941
 US2003211603
 US2004235175
 US6833269
 EP1507865
 US6991897
 US7015037
 US2007048864
 US2007048865
 US2007072295
 US2007238170
 US2008108044
 US7399632
 US7410798
 US7410773
 US7422736
 US2008260706
 US2009148425
 US20090058858
 US20090172079
 US19950464599
 WO2004US30606
 US20090184546
 WO2010IB00154
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.